Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of multidimensional poverty in antibiotic misuse: a mixed-methods study of self-medication and non-adherence in Kenya, Tanzania, and Uganda.
Green DL, Keenan K, Fredricks KJ, Huque SI, Mushi MF, Kansiime C, Asiimwe B, Kiiru J, Mshana SE, Neema S, Mwanga JR, Kesby M, Lynch AG, Worthington H, Olamijuwon E, Abed Al Ahad M, Aduda A, Njeru JM, Mmbaga BT, Bazira J, Sandeman A, Stelling J, Gillespie SH, Kibiki G, Sabiiti W, Sloan DJ, Holden MTG; HATUA Consortium. Green DL, et al. Among authors: gillespie sh. Lancet Glob Health. 2023 Jan;11(1):e59-e68. doi: 10.1016/S2214-109X(22)00423-5. Lancet Glob Health. 2023. PMID: 36521953 Free article.
Systematic assessment of clinical and bacteriological markers for tuberculosis reveals discordance and inaccuracy of symptom-based diagnosis for treatment response monitoring.
Mtafya B, Sabi I, John J, Sichone E, Olomi W, Gillespie SH, Ntinginya NE, Sabiiti W. Mtafya B, et al. Among authors: gillespie sh. Front Med (Lausanne). 2022 Oct 28;9:992451. doi: 10.3389/fmed.2022.992451. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36419786 Free PMC article.
A practical approach to render tuberculosis samples safe for application of tuberculosis molecular bacterial load assay in clinical settings without a biosafety level 3 laboratory.
Mtafya B, Qwaray P, John J, Sichone E, Shoo A, Gillespie SH, Ntinginya NE, Sabiiti W. Mtafya B, et al. Among authors: gillespie sh. Tuberculosis (Edinb). 2023 Jan;138:102275. doi: 10.1016/j.tube.2022.102275. Epub 2022 Nov 15. Tuberculosis (Edinb). 2023. PMID: 36434867 Free article.
Corrigendum to "A practical approach to render tuberculosis samples safe for application of tuberculosis molecular bacterial load assay in clinical settings without a biosafety level 3 laboratory" [Tuberculosis 138 (2023) 102275 1-5].
Mtafya B, Qwaray P, John J, Sichone E, Shoo A, Gillespie SH, Ntinginya NE, Sabiiti W. Mtafya B, et al. Among authors: gillespie sh. Tuberculosis (Edinb). 2023 Sep;142:102321. doi: 10.1016/j.tube.2023.102321. Epub 2023 Feb 16. Tuberculosis (Edinb). 2023. PMID: 36803916 No abstract available.
Urogenital pathogens in urine samples of clinically diagnosed urinary tract infected patients in Tanzania: A laboratory based cross-sectional study.
Msemwa B, Mushi MF, Kidenya B, Okamo B, Keenan K, Sabiiti W, Miyaye DN, Konje ET, Silago V, Mirambo MM, Mwanga JR, Gillespie S, Maldonado-Barragan A, Sandeman A, Holden M, Mshana SE. Msemwa B, et al. IJID Reg. 2022 Dec 27;7:170-175. doi: 10.1016/j.ijregi.2022.12.007. eCollection 2023 Jun. IJID Reg. 2022. PMID: 37069922 Free PMC article.
Bacterial etiology of urinary tract infections in patients treated at Kenyan health facilities and their resistance towards commonly used antibiotics.
Kiiru S, Maina J, Katana J, Mwaniki J, Asiimwe BB, Mshana SE, Keenan K, Gillespie SH, Stelling J, Holden MTG; HATUA Consortium; Kiiru J. Kiiru S, et al. Among authors: gillespie sh. PLoS One. 2023 May 26;18(5):e0277279. doi: 10.1371/journal.pone.0277279. eCollection 2023. PLoS One. 2023. PMID: 37235625 Free PMC article.
Unravelling patient pathways in the context of antibacterial resistance in East Africa.
Keenan K, Fredricks KJ, Al Ahad MA, Neema S, Mwanga JR, Kesby M, Mushi MF, Aduda A, Green DL, Lynch AG, Huque SI, Mmbaga BT, Worthington H, Kansiime C, Olamijuwon E, Ntinginya NE, Loza O, Bazira J, Maldonado-Barragán A, Smith V, Decano AG, Njeru JM, Sandeman A, Stelling J, Elliott A, Aanensen D, Gillespie SH, Kibiki G, Sabiiti W, Sloan DJ, Asiimwe BB, Kiiru J, Mshana SE, Holden MTG; HATUA Consortium. Keenan K, et al. Among authors: gillespie sh. BMC Infect Dis. 2023 Jun 19;23(1):414. doi: 10.1186/s12879-023-08392-9. BMC Infect Dis. 2023. PMID: 37337134 Free PMC article.
Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials.
Musisi E, Wyness A, Eldirdiri S, Dombay E, Mtafya B, Ntinginya NE, Heinrich N, Kibiki GS, Hoelscher M, Boeree M, Aarnoutse R, Gillespie SH, Sabiiti W; PanACEA consortium. Musisi E, et al. Among authors: gillespie sh. Lancet Microbe. 2023 Nov;4(11):e913-e922. doi: 10.1016/S2666-5247(23)00191-X. Epub 2023 Oct 10. Lancet Microbe. 2023. PMID: 37832571 Free article.
Building sustainable clinical trial sites in Sub-Saharan Africa through networking, infrastructure improvement, training and conducting clinical studies: The PanACEA approach.
Mekota AM, Gillespie SH, Hoelscher M, Diacon AH, Dawson R, Churchyard G, Sanne I, Minja L, Kibiki G, Maboko L, Lakhi S, Joloba M, Alabi A, Kirenga B, McHugh TD, Grobusch MP, Boeree MJ; PanACEA consortium. Mekota AM, et al. Among authors: gillespie sh. Acta Trop. 2023 Feb;238:106776. doi: 10.1016/j.actatropica.2022.106776. Epub 2022 Dec 8. Acta Trop. 2023. PMID: 36502888
274 results